Gene · 64761
Papers1,639
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,639
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human mRNA in saliva can correctly identify individuals harboring acute infection. | mBio | 2023 | 37943059 | PubTator, text mining | PubMed |
| Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS/STING pathway. | JCI Insight | 2023 | 37937640 | PubTator, text mining | PubMed |
| Sperm DNA fragmentation testing in clinical management of reproductive medicine. | Reprod Med Biol | 2023 | 37915974 | PubTator, text mining | PubMed |
| Exploring pharmacokinetics of talazoparib in ABCB1/ABCG2-deficient mice using a novel UHPLC-MS/MS method. | Heliyon | 2023 | 37908705 | PubTator, text mining | PubMed |
| ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification. | J Biol Chem | 2023 | 37898399 | PubTator, text mining | PubMed |
| Discovery of novel 2,3,4,5-tetrahydrospiro[benzo[c]azepine-1,1'-cyclohexan]-5-ol derivatives as PARP-1 inhibitors. | BMC Chem | 2023 | 37891641 | PubTator, text mining | PubMed |
| A small-molecule inhibitor of TopBP1 exerts anti-MYC activity and synergy with PARP inhibitors. | Proc Natl Acad Sci U S A | 2023 | 37878724 | PubTator, text mining | PubMed |
| Methimazole, an Effective Neutralizing Agent of the Sulfur Mustard Derivative 2-Chloroethyl Ethyl Sulfide. | ACS Bio Med Chem Au | 2023 | 37876493 | PubTator, text mining | PubMed |
| Construction of a novel prognostic model in skin cutaneous melanoma based on chemokines-related gene signature. | Sci Rep | 2023 | 37875556 | PubTator, text mining | PubMed |
| PARP10 is Critical for Stress Granule Initiation. | bioRxiv | 2023 | 37873303 | PubTator, text mining | PubMed |
| Novel Chemotherapy Modalities for Different Cancers. | Cureus | 2023 | 37859875 | PubTator, text mining | PubMed |
| Similarities and differences in gene expression profiles of BRCA1 methylated and mutated epithelial ovarian cancers. | Front Oncol | 2023 | 37854675 | PubTator, text mining | PubMed |
| Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China. | Target Oncol | 2023 | 37847485 | PubTator, text mining | PubMed |
| HTS discovery of PARP1-HPF1 complex inhibitors in cancer. | SLAS Discov | 2023 | 37844763 | PubTator, text mining | PubMed |
Discovery of Quinazoline-2,4(1H,3H)-dione Derivatives Containing a Piperizinone Moiety as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis. | J Med Chem | 2023 | 37843892 | PubTator, text mining | PubMed |
| Integration of bioinformatics and machine learning strategies identifies APM-related gene signatures to predict clinical outcomes and therapeutic responses for breast cancer patients. | Neoplasia | 2023 | 37839160 | PubTator, text mining | PubMed |
| The Complex Network of ADP-Ribosylation and DNA Repair: Emerging Insights and Implications for Cancer Therapy. | Int J Mol Sci | 2023 | 37834477 | PubTator, text mining | PubMed |
| ADP-ribosylation from molecular mechanisms to therapeutic implications. | Cell | 2023 | 37832523 | PubTator, text mining | PubMed |
| Hepatitis B virus infection disrupts homologous recombination in hepatocellular carcinoma by stabilizing resection inhibitor ADRM1. | J Clin Invest | 2023 | 37815873 | PubTator, text mining | PubMed |
| Intracellular FGF1 protects cells from apoptosis through direct interaction with p53. | Cell Mol Life Sci | 2023 | 37783936 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64761/papers?page=9